Commercially Available Bioengineered Cartilage Grafts

The goals of managing patients with symptomatic chondral defects of the knee include optimizing clinical and functional outcomes, generating durable hyaline or hyaline-like cartilage with low procedure-associated morbidity, utilizing cost-effective technology, and ultimately delaying the development of osteoarthritis. The objective of this chapter is to provide an overview of the different types of commercially available bioengineered cartilage grafts including cell-based therapies, microfracture augmentation techniques, and the use of particulated articular cartilage, as well as examples of scaffold and synthetic materials that can be used in isolation.